Inhibition of human parainfluenza virus type 3 infection by novel small molecules
- 29 February 2008
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 77 (2), 83-94
- https://doi.org/10.1016/j.antiviral.2007.09.001
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3Antiviral Research, 2006
- Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory diseaseJCI Insight, 2005
- Prospective therapeutic applications of p53 inhibitorsBiochemical and Biophysical Research Communications, 2005
- Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway EpitheliumJournal of Virology, 2005
- A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse heartsLaboratory Investigation, 2004
- Phase 2 Evaluation of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine in Healthy Children 6–18 Months OldThe Journal of Infectious Diseases, 2004
- Severe Lower Respiratory Tract Infections Associated with Human Parainfluenza Viruses 1-3 in Children Infected and Noninfected with HIV Type 1European Journal of Clinical Microbiology & Infectious Diseases, 2002
- Interferon Action against Human Parainfluenza Virus Type 3: Involvement of a Novel Antiviral Pathway in the Inhibition of TranscriptionJournal of Virology, 2001
- Polarity of Human Parainfluenza Virus Type 3 Infection in Polarized Human Lung Epithelial A549 Cells: Role of Microfilament and MicrotubuleJournal of Virology, 2001
- Human Parainfluenza Virus Type 3 Inhibits Gamma Interferon-Induced Major Histocompatibility Complex Class II Expression Directly and by Inducing Alpha/Beta InterferonJournal of Virology, 2001